Buprenorfin (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Buprenorfin" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

1^st place

2^nd place

4^th place

4^th place

13^th place

447^th place

792^nd place

1,712^th place

7,978^th place

3^rd place

6^th place

4,581^st place

low place

399^th place

480^th place

books.google.com

Bonewit-West, Kathy; Hunt, Sue A.; Applegate, Edith (2012). Today's Medical Assistant: Clinical and Administrative Procedures (dalam bahasa Inggris). Elsevier Health Sciences. hlm. 571. ISBN 9781455701506. Diarsipkan dari versi asli tanggal 28 July 2020. Diakses tanggal 29 July 2020.

Health Canada (6 December 2004). "ARCHIVED - Report Stakeholder Workshop on a National Buprenorphine Program". aem. Diarsipkan dari versi asli tanggal 26 March 2020. Diakses tanggal 10 January 2020.

Mendelson J, Upton RA, Everhart ET, Jacob P, Jones RT (January 1997). "Bioavailability of sublingual buprenorphine". Journal of Clinical Pharmacology. 37 (1): 31–7. doi:10.1177/009127009703700106. PMID 9048270.
Eriksen J, Jensen NH, Kamp-Jensen M, Bjarnø H, Friis P, Brewster D (November 1989). "The systemic availability of buprenorphine administered by nasal spray". The Journal of Pharmacy and Pharmacology. 41 (11): 803–5. doi:10.1111/j.2042-7158.1989.tb06374.x. PMID 2576057.

"Buprenorphine Hydrochloride". drugs.com. American Society of Health-System Pharmacists. 26 January 2017. Diarsipkan dari versi asli tanggal 18 July 2017. Diakses tanggal 17 March 2017.

[https://web.archive.org/web/20201030071038/https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205637s000lbl.pdf Diarsipkan 30 October 2020 di Wayback Machine. BUNAVAIL (buprenorphine and naloxone) buccal film, CIII [prescribing information online]]. BioDelivery BioDelivery Sciences International, Inc. (BDSI), Raleigh, NC. Jun 2014.

Mendelson J, Upton RA, Everhart ET, Jacob P, Jones RT (January 1997). "Bioavailability of sublingual buprenorphine". Journal of Clinical Pharmacology. 37 (1): 31–7. doi:10.1177/009127009703700106. PMID 9048270.
Eriksen J, Jensen NH, Kamp-Jensen M, Bjarnø H, Friis P, Brewster D (November 1989). "The systemic availability of buprenorphine administered by nasal spray". The Journal of Pharmacy and Pharmacology. 41 (11): 803–5. doi:10.1111/j.2042-7158.1989.tb06374.x. PMID 2576057.

"Buprenorphine / Naloxone Buccal Film (BUNAVAIL) C-III" (PDF). Pharmacy Benefits Management (PBM) Services. September 2014. Diarsipkan dari versi asli (PDF) tanggal 20 October 2020.

Health Canada (6 December 2004). "ARCHIVED - Report Stakeholder Workshop on a National Buprenorphine Program". aem. Diarsipkan dari versi asli tanggal 26 March 2020. Diakses tanggal 10 January 2020.
Bonewit-West, Kathy; Hunt, Sue A.; Applegate, Edith (2012). Today's Medical Assistant: Clinical and Administrative Procedures (dalam bahasa Inggris). Elsevier Health Sciences. hlm. 571. ISBN 9781455701506. Diarsipkan dari versi asli tanggal 28 July 2020. Diakses tanggal 29 July 2020.
"Buprenorphine / Naloxone Buccal Film (BUNAVAIL) C-III" (PDF). Pharmacy Benefits Management (PBM) Services. September 2014. Diarsipkan dari versi asli (PDF) tanggal 20 October 2020.
"Buprenorphine Hydrochloride". drugs.com. American Society of Health-System Pharmacists. 26 January 2017. Diarsipkan dari versi asli tanggal 18 July 2017. Diakses tanggal 17 March 2017.
"Press Announcements – FDA approves first buprenorphine implant for treatment of opioid dependence". FDA (dalam bahasa Inggris). Diarsipkan dari versi asli tanggal 30 November 2017. Diakses tanggal 12 December 2017.